A detailed history of Oup Management Co., LLC transactions in E Ffector Therapeutics, Inc. stock. As of the latest transaction made, Oup Management Co., LLC holds 1,025,697 shares of EFTR stock, worth $0. This represents 1.38% of its overall portfolio holdings.

Number of Shares
1,025,697
Previous 1,025,697 -0.0%
Holding current value
$0
Previous $851,000 27.73%
% of portfolio
1.38%
Previous 1.45%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

BUY
$5.71 - $13.15 $5.86 Million - $13.5 Million
1,025,697 New
1,025,697 $8.49 Million

Others Institutions Holding EFTR

About eFFECTOR Therapeutics, Inc.


  • Ticker EFTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,452,800
  • Description
  • eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-sma...
More about EFTR
Track This Portfolio

Track Oup Management Co., LLC Portfolio

Follow Oup Management Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oup Management Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oup Management Co., LLC with notifications on news.